Registry-based analysis reveals significant racial and ethnic disparities in esketamine trial recruitment, indicating a need for improved diversity efforts.
Esketamine clinical trials demonstrate significant racial and ethnic disparities, with underrepresentation of racial and ethnic minority groups. Regulatory efforts to improve diversity must lead to more effective recruitment for fair representation in future research.
No takes yet. Share an insight, caveat, or question.
Świeczkowski et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: